Healthy volunteer
Conditions
Interventions
Intake of tablets containing P-chondroitin for 12 weeks
Intake of tablets that don'
t contain P-chondroitin (placebo) for 12 weeks
Sponsors
Soiken Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject, aged from 30 to 65 years males and females with pain of knee 2) Subject, be diagnosed KLgrade 0 or 1 3) Subject, upon briefing of the content of the present study, fully understanding and agreeing to its objective; and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1)Subjects having a medical history of rheumatism 2)Subjects who have leg pain or numbness 3)Subjects who have injury of semi-lunar disc or the other knee joint disease 4) Subjects receiving treatment for osteoarthritis 5) Subject receiving treatment for serious liver, renal, cardio-vascular, respiratory, endocrine, or metabolic disorders 6) Subject presenting known allergy or history of pork 7) For female subject: pregnancy or breast feeding, or possibility of pregnancy, or intention to be pregnant during the study 8) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 9) Subject who took part in another clinical trial within 3 months prior to the start of the present study or who is currently taking part in another clinical trial 10) Subject deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| JKOM and VAS (pain, stiffness and discomfort of the knee) | — |
Secondary
| Measure | Time frame |
|---|---|
| JOA score | — |
Countries
Japan
Contacts
Public ContactTomohiro Sugino
Soiken Inc. Representative Director
Outcome results
None listed